| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/27/2011 | EP2102199B1 Antibacterial polycyclic urea compounds |
| 04/27/2011 | EP2090575B1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1177796B1 Medicament for prevention or therapeutic treatment of liver disease |
| 04/27/2011 | CN102036996A Bridged heterocycles as HIV integrase inhibitors |
| 04/27/2011 | CN102036989A Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036988A Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036987A Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036986A Conversion of tryptophan into beta-carboline derivatives |
| 04/27/2011 | CN102036972A Treatment of duchenne muscular dystrophy |
| 04/27/2011 | CN102036959A Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036955A Hydroxamate-based inhibitors of deacetylases b |
| 04/27/2011 | CN102030753A Prenylated indole alkaloids and preparation method and application thereof |
| 04/27/2011 | CN102030752A Method for preparing compound 2-(imidazo [1, 2-a] pyridine-3-yl) acetonitrile |
| 04/27/2011 | CN102030751A Process for crystallizing moxifloxacin hydrochloride |
| 04/27/2011 | CN102030750A Novel tetrahydro-1H-pyrido [4,3-b] indole derivatives as CB1' receptor ligands |
| 04/27/2011 | CN102030749A Novel process and formulations |
| 04/27/2011 | CN102030748A Novel process and formulations |
| 04/27/2011 | CN101374831B Tetrahydropyrane antibiotics |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932389 Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof |
| 04/26/2011 | US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 04/26/2011 | US7932281 Amine-based compound and use thereof |
| 04/26/2011 | US7932259 Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group |
| 04/26/2011 | US7932252 CCR9 chemokine receptor modulators; treating inflammatory and immune diseases; inhibit the binding of chemokines, such as TECK (thymus-expressed chemokine), to the CCR9 receptor; 1-arylsulfonamido-2-aryl(alkyl)benzene compounds |
| 04/26/2011 | US7932251 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| 04/26/2011 | CA2601458C Benzimidazolone derivatives as cb2 receptor ligands |
| 04/26/2011 | CA2500952C Neurologically-active compounds |
| 04/26/2011 | CA2491506C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446461C Substituted cyclohexane-1,4-diamine derivatives |
| 04/21/2011 | WO2011047320A2 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | WO2011047192A2 Protected amine labels and use in detecting analytes |
| 04/21/2011 | WO2011046997A1 Cgrp receptor antagonists |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | WO2011046851A1 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes |
| 04/21/2011 | WO2011045561A2 Herbicidal compounds |
| 04/21/2011 | WO2011045353A1 Indole and azaindole modulators of the alpha 7 nachr |
| 04/21/2011 | WO2011045344A1 Pyrazolopyridine derivatives as anticancer agent |
| 04/21/2011 | WO2011045330A1 Macrocyclic integrase inhibitors |
| 04/21/2011 | WO2011045258A1 Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor |
| 04/21/2011 | WO2011017347A3 Mesoionic pesticides |
| 04/21/2011 | WO2010150281A3 Novel azabicyclohexanes |
| 04/21/2011 | US20110092704 Preparation of triazospiro compounds |
| 04/21/2011 | US20110092539 Indane derivatives as ampa receptor modulators |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092536 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 04/21/2011 | US20110092535 Novel Epilepsy Treatment |
| 04/21/2011 | US20110092534 Ammosamides as Anticancer Agents |
| 04/21/2011 | US20110092531 Novel Spiropiperidine Compounds |
| 04/21/2011 | US20110092529 1,2,4-Triazole Derivatives and Their Use as Oxytocin Antagonists |
| 04/21/2011 | US20110092528 Piperidinyl compounds that selectively bind integrins |
| 04/21/2011 | US20110092527 4 (Pyrrolopyridinyl)pyrimidin-2-ylamine derivatives |
| 04/21/2011 | US20110092525 Gabaa receptor modulators |
| 04/21/2011 | US20110092511 Inhibitors of akt activity |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092495 Compounds for the treatment of multi-drug resistant bacterial infections |
| 04/21/2011 | US20110092494 Tricyclic Tetrahydroquinoline Antibacterial Agents |
| 04/21/2011 | US20110092487 Novel 3,8-diaza-bicyclo[3.2.1]octane-and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/21/2011 | US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions |
| 04/21/2011 | US20110092479 Pyrazole [3, 4-b] pyridine raf inhibitors |
| 04/21/2011 | US20110092477 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 04/21/2011 | US20110092475 2-substituted-ethynylthiazole derivatives and uses of same |
| 04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
| 04/21/2011 | US20110091390 Water soluble tetrapyrollic photosensitizers for photodynamic therapy |
| 04/21/2011 | US20110091382 Novel imaging agents for detecting neurological dysfunction |
| 04/21/2011 | CA2777775A1 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes |
| 04/21/2011 | CA2777739A1 Antimicrobial compounds and methods of making and using the same |
| 04/21/2011 | CA2777664A1 Macrocyclic integrase inhibitors |
| 04/21/2011 | CA2777518A1 Cgrp receptor antagonists |
| 04/21/2011 | CA2777509A1 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system |
| 04/21/2011 | CA2776835A1 Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor |
| 04/21/2011 | CA2773604A1 Herbicidal compounds |
| 04/20/2011 | EP2311837A1 Azaindoles useful as inhibitors of jak and other protein kinases |
| 04/20/2011 | EP2311836A1 Process for preparing naphthyridine derivatives. |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/20/2011 | EP2311823A1 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| 04/20/2011 | EP2311814A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents |
| 04/20/2011 | EP2311811A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311807A1 Compounds and composition as protein kinase inhibitors |
| 04/20/2011 | EP2310389A1 Heterocycles as protein kinase inhibitors |
| 04/20/2011 | EP2310388A2 Pyridopyrimidine compounds as anti-tubercular agents |
| 04/20/2011 | EP2310381A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer |
| 04/20/2011 | EP2310373A1 Bicyclic heterocycles as mek kinase inhibitors |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP2310019A2 5-ht3 receptor modulators, methods of making, and use thereof |
| 04/20/2011 | EP2310015A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 04/20/2011 | EP2240479B1 Novel nitrogen-containing organic compounds that can be used as precursor of a catalytic composition |
| 04/20/2011 | EP1919922B1 Method for synthesizing spiro quaternary ammonium systems |
| 04/20/2011 | EP1761533B1 1-aza-bicyclo[3.3.1]nonanes |
| 04/20/2011 | EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | CN102027613A 有机电致发光器件 Organic electroluminescent devices |
| 04/20/2011 | CN102027611A N-type semiconductor materials in thin film transistors |